中文

1

current position：

/

development path

Information technology

Clinical resources

academic seminar

2021-07-18

On January 25, 2016, Duzheng Biotech was formally established
2021-07-17

On October 24, 2016, the first medicine was established
2021-07-16

On December 27, 2016, the establishment of the data
2021-07-15

April 10, 2017 Established Tongnuo Information
2021-07-14

July 26, 2017 Established Medical Laboratory
2021-07-13

On October 17, 2018, Duzheng Biotech and Xianling Medicine were recognized as high-tech enterprises
2021-07-11

On October 17, 2018, Duzheng Biotech and Xianling Medicine were recognized as high-tech enterprises
2021-07-10

On July 22, 2020, the founding meeting of Changsha Duzheng Biotechnology Co., Ltd. was successfully held
2021-07-09

July 23, 2021 Changsha Duzheng Medical Laboratory was officially opened for business

Previous page

1

Next page

2021-12-14

Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!
2021-11-29

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved
2021-11-22

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved
2021-11-17

On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved
2021-09-16

September 9th, 2021, the first national approval of Ritonavir Tablets by Guli Pharmaceutical (Zhejiang) Co., Ltd.
2021-09-16

September 3, 2021 Hainan General Sanyo Pharmaceutical Co., Ltd. Vidagliptin tablets were successfully approved
2021-08-25

On August 12, 2021, Zhejiang Hisun Pharmaceutical Co., Ltd.'s valsartan tablets were approved
2021-08-26

On August 19, 2021, Chengdu Hengrui Pharmaceutical Co., Ltd. received approval for cetirizine hydrochloride tablets
2021-09-16

September 13, 2021 Hunan Warner Pharmaceutical Co., Ltd. Entecavir Granules is the first nationwide approved
2019-07-04

On July 4, 2019, Zhejiang Hisun Pharmaceutical Co., Ltd. was approved as the third company in the country for Solina Succinate New Tablets
2020-02-05

February 5, 2020, Jilin Province West Point Pharmaceutical Technology Development Co., Ltd. Escitalopram oxalate tablets were approved
2020-06-02

On June 2, 2020, Zhejiang Hisun Pharmaceutical Co., Ltd. was the first nationwide approval for donepezil hydrochloride orally disintegrating tablets
2020-07-02

On July 2, 2020, Hangzhou Kangenbei Pharmaceutical Co., Ltd. was the first nationally approved pantoprazole sodium enteric-coated tablet
2020-07-13

July 13, 2020 Hunan Jiudian Pharmaceutical Co., Ltd. Pantoprazole sodium enteric-coated tablets is the second nationwide
2020-07-29

On July 29, 2020, Gale Biotechnology (Hangzhou) Co., Ltd. was successfully approved as a Class 1 new drug for hepatitis C, Lavidavir Hydrochloride
2020-10-26

On October 26, 2020 Hunan Warner Pharmaceutical Co., Ltd. was the first nationally approved bismuth potassium citrate capsule
2020-10-29

On October 29, 2020, Zhuhai Tongyi Pharmaceutical Co., Ltd. obtained the third national approval for nateglinide tablets
2021-07-19

November 24, 2020 Hunan Jiudian Pharmaceutical Co., Ltd. Irbesartan tablets were successfully approved
2018-05-14

On May 14, 2018 Hunan Dongting Pharmaceutical Co., Ltd. received the second national approval of Escitalopram oxalate tablets
2021-07-19

On January 29, 2021, the Amoxicillin Capsule (0.25g) of Haikou Pharmaceutical Factory Co., Ltd. was successfully approved
2021-07-19

On January 29, 2021, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. successfully approved clozapine tablets
2021-07-19

March 9, 2021 Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban tablets were successfully approved
2021-07-19

On March 12, 2021, Hainan Ludao Pharmaceutical Co., Ltd. was successfully approved for terazosin hydrochloride tablets
2021-07-19

April 20, 2021 Hunan Dongting Pharmaceutical Co., Ltd. clozapine tablets were successfully approved
2021-07-19

April 30, 2021 Jiangsu Tianyishi Pharmaceutical Co., Ltd. Moxifloxacin Hydrochloride Tablets was successfully approved
2021-07-19

May 11, 2021 Tiandi Hengyi Pharmaceutical Co., Ltd. successfully approved tofacitib citrate tablets
2021-07-19

July 20, 2021 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Olopatadine Hydrochloride Tablets was approved for the third nationwide
2021-07-19

July 22, 2021 Hunan Xiangzhong Pharmaceutical Co., Ltd. Sodium Valproate Tablets was approved as the third nationwide company

Previous page

1

Next page

2021-11-05

On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)
2021-11-05

On October 10, 2020, China's first intelligent laboratory management platform (ILP) was released
2021-11-05

In July 2020, yootrial auth joined hands with Guangdong Hong Kong Macao alliance and Pacific Medical Subject Information Management System (escreening) to realize mutual check of subject identity information among the three systems
2017-04-10

In April 2017, Tongnuo Information was established to independently develop pharmacy and clinical information systems
2018-03-01

In March 2018, the intelligent biological sample bank management system (Pharm BioBank) V1.0 was released
2018-03-30

March 2018 Yootrial AUTH V1.0 was launched
2018-04-22

In April 2018, the recruitment and management platform for volunteers from the fundraiser was launched.
2018-06-25

June 2018 Bioanalysis Laboratory Information Management System (PharmLIMS for DMPK) V1.0 was released
2018-11-20

In November 2018, the electronic data acquisition system (YooTrial EDC) V1.0 was released
2018-12-15

In December 2018, the clinical trial project management system (YooTrial CTMS) V1.0 was released
2019-04-06

April 2019 YooTrial Ethics V1.0 released
2019-06-27

In June 2019, the intelligent biological sample bank management system Pharm BioBank) V2.0 was released
2019-09-17

In September 2019, it successfully signed a contract with the Guangdong-Hong Kong-Macao Phase I clinical research joint platform to jointly build a subject database
2019-11-11

In November 2019, the Pharmaceutical Research Laboratory Information Management System (PharmLIMS) V1.0 was released
2020-05-01

In May 2020, Yootrial Auth and Taimei Medical eScreening officially opened up
2020-07-01

In July 2020, YooTrial Auth joined forces with the Guangdong-Hong Kong-Macao Alliance and Taimei Medical Subject Information Management System (eScreening) to achieve mutual check of subject identity information among the three-party systems
2020-10-30

On 10, 2020, the first domestic intelligent laboratory management platform (ILP) was released
2021-01-25

On 1st, 2021, Tongnuo Information releases the internal beta version of the Intelligent Clinical Research Management Platform (ICP)

Previous page

1

Next page

2021-06-21

October 2016 Signed a framework agreement to jointly build a clinical research center with the Affiliated Hospital of Shonan College
2021-06-22

In November 2016, cooperated with Hunan Provincial Occupational Disease Prevention and Treatment Institute to build a clinical research center
2021-06-23

May 2017 Join hands with Changsha Central Hospital to build a clinical research center
2021-06-24

May 2017 Join hands with Hunan Provincial Brain Hospital to build a clinical research center
2021-06-25

In June 2017, it cross-provincial for the first time, and cooperated with Nanning Second People's Hospital to build a clinical research center
2021-06-26

July 2017 Signed contract with Hunan Chest Hospital to promote hospital GCP and decode tuberculosis diagnosis and treatment
2021-06-27

In September 2017, cooperated with Changsha Traditional Chinese Medicine Hospital (Changsha Eighth Hospital) to build a drug clinical trial base
2021-06-28

September 2017 Join hands with Wuhan Mental Health Center to build a clinical research center
2021-06-29

In September 2017, signed a phase I clinical trial laboratory cooperation agreement with Hunan Cancer Hospital
2021-06-30

In September 2017, it reached a clinical research strategic cooperation with Mengchao Hepatobiliary Hospital of Fujian Medical University
2021-07-01

In November 2017, it reached a clinical research strategic cooperation with Xianning Central Hospital
2021-07-02

In November 2017, it reached a clinical research strategic cooperation with the First People's Hospital of Huaihua City
2021-07-03

In January 2018, cooperated with Hunan Kangya Hospital to carry out phase I/BE clinical trial business
2021-07-04

In January 2018, cooperated with the Second People's Hospital of Neijiang City, Sichuan Province to build a clinical research center
2021-07-05

March 2018 Join hands with the First Affiliated Hospital of Chengdu Medical College to build a clinical research center
2021-07-06

July 2018 Join hands with Hunan Provincial Maternity and Child Health Hospital to build a clinical research center
2021-07-07

In November 2018, signed an in-depth strategic cooperation agreement with the Hunan Provincial Occupational Disease Prevention and Treatment Institute
2021-07-08

In April 2019, join hands with Huaihua Second People's Hospital to build a clinical research center
2021-07-09

In May 2019, it reached a strategic cooperation with Hunan Provincial People's Hospital
2021-07-10

September 2019 Duzheng Bio-Hunan Provincial People's Hospital Co-built Clinical Research Center was officially opened
2021-07-11

In November 2019, instructed Zhoukou Central Hospital to carry out the qualification accreditation of drug clinical trial institutions
2021-07-12

March 2020 Co-established a clinical research center with Changsha Kexin Cancer Hospital
2021-07-15

July 2020 Signed a contract with Yuebei People's Hospital to build a clinical research center
2021-07-13

March 2020 Co-built clinical research center with Huxiang Traditional Chinese Medicine Tumor Hospital (People's Hospital of Yuelu District, Changsha City)
2021-07-14

May 2020 Co-established a clinical research center with CITIC Xiangya Reproductive and Genetic Hospital
2021-07-16

July 2020 reached a strategic cooperation with the First Affiliated Hospital of Guangdong Pharmaceutical University
2021-07-17

July 2020 Signed a contract with Loudi Central Hospital to build a clinical research center
2021-07-18

In September 2020, it reached a strategic cooperation with Chongqing West District Hospital Co., Ltd.
2021-07-19

In November 2020, it reached a strategic cooperation with the Second People's Hospital of Yueyang City
2021-07-20

In December 2020, a clinical research center was established with Guangdong Occupational Disease Prevention and Treatment Institute
2021-07-21

January 2021 Co-build a clinical research center with Changsha Maternal and Child Health Hospital
2021-07-22

January 2021 Co-built clinical research center with Qinzhou First People's Hospital
2021-07-23

February 2021 and Zhuzhou Traditional Chinese Medicine Trauma Hospital to build a medical device clinical research center
2021-07-24

March 2021 Deepen the strategic cooperation with the Clinical Research Center of Hunan Provincial People's Hospital
2021-07-25

In April 2021, a clinical research center was established with the First People's Hospital of Hengyang City
2021-07-26

May 2021 Co-build clinical research center with Hengyang Central Hospital
2021-07-27

May 2021 Co-build clinical research center with Xiangya Boai Rehabilitation Hospital
2021-07-28

June 2021 Co-built clinical research center with Jiangxi Pingxiang Mining Group Co., Ltd. General Hospital

Previous page

1

Next page

2021-07-15

May 30, 2019 PPI Pharmacy Clinical Consistency Evaluation Symposium Beijing Station
2021-07-16

June 28, 2019 BE Pre-test Results Interpretation Seminar Haikou Station
2021-07-17

Seminar on Interpretation of BE Pre-test Results on July 12, 2019 Wuhan Station
2021-07-18

July 26, 2019 Difficulties of Highly Variant Drug BE and Case Analysis Seminar on Oral Proton Pump Inhibitors Chengdu Station
2021-07-19

September 6, 2019 Highly Variant Drug BE Difficulties and Oral Proton Pump Inhibitor Case Analysis Seminar Jinan Station
2021-07-20

November 8, 2019 Highly mutated drug BE difficulties and oral proton pump inhibitor case analysis seminar Guangzhou station
2021-07-21

December 11, 2019 Difficulties of highly variable drugs BE and oral proton pump inhibitor case analysis seminar Kunming Station
2021-07-23

December 25, 2019 Highly Variant Drug BE Difficulties and Oral Proton Pump Inhibitor Case Analysis Seminar Shanghai Station
2021-07-22

Online live broadcast on March 22, 2020-Pantoprazole sodium enteric-coated tablets research and development case sharing
2021-07-24

March 26, 2020 Online live broadcast-BE traps in PPI research
2021-07-25

April 29, 2020 Online live broadcast-from PPI trap to Esomeprazole drug development case sharing
2021-07-26

August 28, 2020 Qingdao Station, Seminar on the Development of Improved New Drugs and Complex Preparations
2021-07-27

October 10, 2020 The 3rd DDI/New Drug Innovation Forum Changsha Station
2021-07-28

May 19, 2021 Improved new drugs & high-end preparation cutting-edge technology salon Jinan Station

Previous page

1

Next page

Online

Online

TEL

0731-85681666-8006

WeChat

WeChat

TOP

搜索

Search

Service Hotline：

0731-85681666-8006

Copyright © 2021 Changsha Duxact Biotech Co., Ltd. 湘ICP备 16006884号-1

www.300.cn Changsha